251 related articles for article (PubMed ID: 34145290)
1. The pan-cancer lncRNA PLANE regulates an alternative splicing program to promote cancer pathogenesis.
Teng L; Feng YC; Guo ST; Wang PL; Qi TF; Yue YM; Wang SX; Zhang SN; Tang CX; La T; Zhang YY; Zhao XH; Gao JN; Wei LY; Zhang D; Wang JY; Shi Y; Liu XY; Li JM; Cao H; Liu T; Thorne RF; Jin L; Shao FM; Zhang XD
Nat Commun; 2021 Jun; 12(1):3734. PubMed ID: 34145290
[TBL] [Abstract][Full Text] [Related]
2. lncRNA-HIT promotes cell proliferation of non-small cell lung cancer by association with E2F1.
Yu L; Fang F; Lu S; Li X; Yang Y; Wang Z
Cancer Gene Ther; 2017 May; 24(5):221-226. PubMed ID: 28429752
[TBL] [Abstract][Full Text] [Related]
3. Cell type-restricted activity of hnRNPM promotes breast cancer metastasis via regulating alternative splicing.
Xu Y; Gao XD; Lee JH; Huang H; Tan H; Ahn J; Reinke LM; Peter ME; Feng Y; Gius D; Siziopikou KP; Peng J; Xiao X; Cheng C
Genes Dev; 2014 Jun; 28(11):1191-203. PubMed ID: 24840202
[TBL] [Abstract][Full Text] [Related]
4. Regulation of alternative splicing of Bcl-x by BC200 contributes to breast cancer pathogenesis.
Singh R; Gupta SC; Peng WX; Zhou N; Pochampally R; Atfi A; Watabe K; Lu Z; Mo YY
Cell Death Dis; 2016 Jun; 7(6):e2262. PubMed ID: 27277684
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA ERICD interacts with ARID3A via E2F1 and regulates migration and proliferation of osteosarcoma cells.
Arman K; Saadat KASM; Igci YZ; Bozgeyik E; Ikeda MA; Cakmak EA; Arslan A
Cell Biol Int; 2020 Nov; 44(11):2263-2274. PubMed ID: 32749762
[TBL] [Abstract][Full Text] [Related]
6. A lncRNA regulates alternative splicing via establishment of a splicing-specific chromatin signature.
Gonzalez I; Munita R; Agirre E; Dittmer TA; Gysling K; Misteli T; Luco RF
Nat Struct Mol Biol; 2015 May; 22(5):370-6. PubMed ID: 25849144
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA EMS connects c-Myc to cell cycle control and tumorigenesis.
Wang C; Yang Y; Zhang G; Li J; Wu X; Ma X; Shan G; Mei Y
Proc Natl Acad Sci U S A; 2019 Jul; 116(29):14620-14629. PubMed ID: 31262817
[TBL] [Abstract][Full Text] [Related]
8. The LncRNA EPEL Promotes Lung Cancer Cell Proliferation Through E2F Target Activation.
Park SM; Choi EY; Bae DH; Sohn HA; Kim SY; Kim YJ
Cell Physiol Biochem; 2018; 45(3):1270-1283. PubMed ID: 29448242
[TBL] [Abstract][Full Text] [Related]
9. Analysis of copy number alterations reveals the lncRNA ALAL-1 as a regulator of lung cancer immune evasion.
Athie A; Marchese FP; González J; Lozano T; Raimondi I; Juvvuna PK; Abad A; Marin-Bejar O; Serizay J; Martínez D; Ajona D; Pajares MJ; Sandoval J; Montuenga LM; Kanduri C; Lasarte JJ; Huarte M
J Cell Biol; 2020 Sep; 219(9):. PubMed ID: 32858747
[TBL] [Abstract][Full Text] [Related]
10. LncRNA SNHG3 is activated by E2F1 and promotes proliferation and migration of non-small-cell lung cancer cells through activating TGF-β pathway and IL-6/JAK2/STAT3 pathway.
Shi J; Li J; Yang S; Hu X; Chen J; Feng J; Shi T; He Y; Mei Z; He W; Xie J; Li S; Jie Z; Tu S
J Cell Physiol; 2020 Mar; 235(3):2891-2900. PubMed ID: 31602642
[TBL] [Abstract][Full Text] [Related]
11. A regulated PNUTS mRNA to lncRNA splice switch mediates EMT and tumour progression.
Grelet S; Link LA; Howley B; Obellianne C; Palanisamy V; Gangaraju VK; Diehl JA; Howe PH
Nat Cell Biol; 2017 Sep; 19(9):1105-1115. PubMed ID: 28825698
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA NEAT1 is a transcriptional target of p53 and modulates p53-induced transactivation and tumor-suppressor function.
Idogawa M; Ohashi T; Sasaki Y; Nakase H; Tokino T
Int J Cancer; 2017 Jun; 140(12):2785-2791. PubMed ID: 28295289
[TBL] [Abstract][Full Text] [Related]
13. E2F1-Induced Overexpression of Long Noncoding RNA SBF2-AS1 Promotes Non-Small-Cell Lung Cancer Metastasis Through Regulating miR-362-3p/GRB2 Axis.
Wang A; Wang J
DNA Cell Biol; 2020 Jul; 39(7):1290-1298. PubMed ID: 32364763
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA H19 is responsible for the progression of lung adenocarcinoma by mediating methylation-dependent repression of CDH1 promoter.
Gao LM; Xu SF; Zheng Y; Wang P; Zhang L; Shi SS; Wu T; Li Y; Zhao J; Tian Q; Yin XB; Zheng L
J Cell Mol Med; 2019 Sep; 23(9):6411-6428. PubMed ID: 31317666
[TBL] [Abstract][Full Text] [Related]
15. A novel variable exonic region and differential expression of LINC00663 non-coding RNA in various cancer cell lines and normal human tissue samples.
Bozgeyik E; Igci YZ; Sami Jacksi MF; Arman K; Gurses SA; Bozgeyik I; Pala E; Yumrutas O; Temiz E; Igci M
Tumour Biol; 2016 Jul; 37(7):8791-8. PubMed ID: 26743782
[TBL] [Abstract][Full Text] [Related]
16. The long non-coding RNA FOXD2-AS1 promotes bladder cancer progression and recurrence through a positive feedback loop with Akt and E2F1.
Su F; He W; Chen C; Liu M; Liu H; Xue F; Bi J; Xu D; Zhao Y; Huang J; Lin T; Jiang C
Cell Death Dis; 2018 Feb; 9(2):233. PubMed ID: 29445134
[TBL] [Abstract][Full Text] [Related]
17. HNRNPM controls circRNA biogenesis and splicing fidelity to sustain cancer cell fitness.
Ho JS; Di Tullio F; Schwarz M; Low D; Incarnato D; Gay F; Tabaglio T; Zhang J; Wollmann H; Chen L; An O; Chan THM; Hall Hickman A; Zheng S; Roudko V; Chen S; Karz A; Ahmed M; He HH; Greenbaum BD; Oliviero S; Serresi M; Gargiulo G; Mann KM; Hernando E; Mulholland D; Marazzi I; Wee DKB; Guccione E
Elife; 2021 Jun; 10():. PubMed ID: 34075878
[TBL] [Abstract][Full Text] [Related]
18. LIN28A Modulates Splicing and Gene Expression Programs in Breast Cancer Cells.
Yang J; Bennett BD; Luo S; Inoue K; Grimm SA; Schroth GP; Bushel PR; Kinyamu HK; Archer TK
Mol Cell Biol; 2015 Sep; 35(18):3225-43. PubMed ID: 26149387
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Splicing Factor 3b Subunit 1 (SF3B1) Reduced Cell Proliferation, Induced Apoptosis and Resulted in Cell Cycle Arrest by Regulating Homeobox A10 (HOXA10) Splicing in AGS and MKN28 Human Gastric Cancer Cells.
Zhang Y; Yuan Z; Jiang Y; Shen R; Gu M; Xu W; Gu X
Med Sci Monit; 2020 Jan; 26():e919460. PubMed ID: 31927557
[TBL] [Abstract][Full Text] [Related]
20. lncRNA NEAT1 facilitates the progression of colorectal cancer via the KDM5A/Cul4A and Wnt signaling pathway.
Shen X; Ye Z; Wu W; Zhao K; Cheng G; Xu L; Gan L; Wu Y; Yang Z
Int J Oncol; 2021 Jul; 59(1):. PubMed ID: 34109988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
